FULC NASDAQ
Fulcrum Therapeutics, Inc.
1W: -1.3%
1M: -4.2%
3M: -0.8%
YTD: -66.2%
1Y: -60.5%
3Y: -19.8%
5Y: -86.6%
$3.69
+0.01 (+0.27%)
Weekly Expected Move ±1.4%
$4
$4
$4
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-85M
Net Income
-16.1% YoY
$-66M
Free Cash Flow
-1.4% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-32.4%
ROA-30.8%
ROIC2389.1%
Valuation
P/E-3.0
P/B0.9
EV/EBITDA0.4
Leverage
Debt/Equity0.02
Current Ratio31.35
Interest Cov.0.0x
Quality Scores
Piotroski F4/9
Altman Z10.23
Beneish M0.00